Health
Results: 1033-1044 of 8106

Alkermes Announces Positive Topline Results From Vibrance-2 Phase 2 Study of Once-Daily Alixorexton in Patients With Narcolepsy Type 2

Genesis Automation Healthcare Announces Strategic Investment from Diversis Capital to Accelerate Global Expansion of Clinical Supply Chain and Inventory Management Platform







